![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 14, 11962-11969, April 4, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Lysophosphatidic acid (LPA) is a bioactive
lysophospholipid mediator that acts through G protein-coupled
receptors. Most cell lines in culture express one or more LPA
receptors, making it difficult to assign a response to specific LPA
receptors. Dissection of the signaling properties of LPA has been
hampered by lack of LPA receptor subtype-specific agonists and
antagonists. The present study characterizes an ester-linked
thiophosphate derivative
(1-oleoyl-2-O-methyl-rac-glycerophosphothionate, OMPT) of LPA. OMPT is a functional LPA analogue with potent
mitogenic activity in fibroblasts. In contrast to LPA, OMPT does not
couple to the pheromone response through the LPA1 receptor
in yeast cells. OMPT induces intracellular calcium increases
efficiently in LPA3 receptor-expressing Sf9 cells
but poorly in LPA2 receptor-expressing cells. Guanosine
5'-O-(3-[35S]thio)triphosphate binding assays
in mammalian cells showed that LPA exhibits agonistic activity on all
three LPA receptor subtypes, whereas OMPT has a potent agonistic effect
only on the LPA3 receptor. In transiently transfected
HEK293 cells, OMPT stimulates mitogen-activated protein kinases through
the LPA3 but not the LPA1 or LPA2
receptors. Furthermore, OMPT-induced intracellular calcium mobilization
in mammalian cells is efficiently inhibited by the
LPA1/LPA3 receptor-selective antagonist
VPC12249. These results establish that OMPT is an
LPA3-selective agonist. OMPT binding to the
LPA3 receptor in mammalian cells is sufficient to elicit
multiple responses, including activation of G proteins, calcium
mobilization, and activation of mitogen-activated protein kinases. Thus
OMPT offers a powerful probe for the dissection of LPA signaling events
in complex mammalian systems.
Identification of a Phosphothionate Analogue of Lysophosphatidic
Acid (LPA) as a Selective Agonist of the LPA3 Receptor*
,
,
,
,
,
,
,
,
,
, and
§§
M. D. Anderson Cancer Center,
Houston, Texas 77030, § LXR Biotechnology,
Richmond, California 94804, the ** University of
Tokyo, Tokyo 113-0033, Japan, and the

Department of Pharmacology, University of
Virginia Health System, Charlottesville, Virginia 22908
*
The work was supported by Atairgin Technologies Contract
LS99-225RG, the Lynne Cohen Foundation Ovarian Cancer Research Grant 80095031 (to X. F.), and by National Institutes of Health Grants CA64602 (to G. B. M.), CA88994, and GM052722 (to K. R. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Genentech Inc., South San Francisco, CA.
§§
To whom correspondence should be addressed: M. D. Anderson
Cancer Center, Dept. of Molecular Therapeutics, Box 317, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-745-1134; Fax: 713-745-1184; E-mail: Xianjunfang@mail.mdanderson.org.
This article has been cited by other articles:
![]() |
M. M. Murph, J. Hurst-Kennedy, V. Newton, D. N. Brindley, and H. Radhakrishna Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells Mol. Cancer Res., November 1, 2007; 5(11): 1201 - 1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Anliker and J. Chun Lysophospholipid G Protein-coupled Receptors J. Biol. Chem., May 14, 2004; 279(20): 20555 - 20558. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hama, J. Aoki, M. Fukaya, Y. Kishi, T. Sakai, R. Suzuki, H. Ohta, T. Yamori, M. Watanabe, J. Chun, et al. Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1 J. Biol. Chem., April 23, 2004; 279(17): 17634 - 17639. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Im Discovery of new G protein-coupled receptors for lipid mediators J. Lipid Res., March 1, 2004; 45(3): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Okusa, H. Ye, L. Huang, L. Sigismund, T. Macdonald, and K. R. Lynch Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury Am J Physiol Renal Physiol, September 1, 2003; 285(3): F565 - F574. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |